Cardiovascular Systems, Inc. CSIIreported earnings per share of a penny in third-quarter fiscal 2018 against the year-ago quarterly loss of 5 cents. The figure remained ahead of the earlier guided range of a loss of 3 cents to breakeven. Moreover, the bottom line compared favorably with the Zacks Consensus Estimate of […]
Financial
Abiomed Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year Revenue of $594 Million, Up 33%, Over Prior Year
DANVERS, Mass., May 03, 2018 — ABIOMED, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart recovery and support technologies, today reported fourth quarter fiscal 2018 revenue of $174.4 million, an increase of 40% compared to revenue of $124.7 million for the same period of fiscal 2017. For fiscal year 2018, total revenue […]
LivaNova Reports First Quarter 2018 Results
LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today reported results for the quarter ended March 31, 2018. For the first quarter of 2018, worldwide sales from continuing operations were $250.4 million, an increase of 10.4 percent on a reported basis and an increase […]
CORRECTING and REPLACING Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance
EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–The fifth bullet in the Recent Highlights section should read: EPS of $0.11, Non-GAAP EPS of $0.07 (instead of EPS of $0.11, Non-GAAP EPS of $0.15). The correct figure of $0.07 is represented in the Second Quarter Fiscal 2018 Financial Results section and throughout the financial tables. […]
Edwards Lifesciences Enters Into Accelerated Share Repurchase Agreement
IRVINE, Calif., May 1, 2018 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced today that it entered into an accelerated share repurchase (ASR) agreement to repurchase an aggregate of $400 million of Edwards’ common stock. Under the terms of this ASR agreement, […]
Zynex Schedules 2018 First Quarter Earnings Release and Webcast
LONE TREE, Colo., May 1, 2018 /PRNewswire/ — Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company’s 2018 first quarter investor webcast on Tuesday, May […]
Biomerics And ATL Technologies Acquire CRI Medical
SALT LAKE CITY and INDIANAPOLIS, April 30, 2018 /PRNewswire/ — Biomerics and ATL Technology, in a joint venture (Biomerics ATL, LLC), announced on Tuesday, April 24, 2018, that they have entered into an agreement under which together they will acquire Catheter Research Inc. (CRI)‘s assets in the Indianapolis and Costa Rica divisions. CRI is a manufacturer of interventional catheters, tube sets, and other […]
LivaNova Enters into Binding Letter of Intent to Sell its Cardiac Rhythm Management Business Franchise to MicroPort Scientific Corporation for $190 Million
LONDON & SHANGHAI–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova”) and MicroPort Scientific Corporation (HK:00853) (“MicroPort”) today announced that the companies have entered into a binding Letter of Intent (“LOI”) for the sale of LivaNova’s Cardiac Rhythm Management (“CRM”) Business Franchise to MicroPort for $190 million in cash. The CRM Business Franchise develops, […]
Teleflex Incorporated to Host Analyst & Investor Day on May 11, 2018
WAYNE, Pa.–(BUSINESS WIRE)–Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices, today announced the agenda for its 2018 Analyst & Investor Day, which will be held on Friday, May 11, 2018. A live webcast of the event presentations will begin at 9:00 a.m. ET. 2018 Analyst & Investor Day […]
AtriCure Reports First Quarter 2018 Financial Results
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced first quarter 2018 financial results. “We are pleased with our first quarter performance and meaningful progress toward completing enrollment in CONVERGE,” said Mike Carrel, President and Chief Executive Officer […]



